Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Mar
15
2023
USPTO Discusses Duty of Disclosure and Duty of Reasonable Inquiry Foley & Lardner LLP
Apr
17
2023
Challenges to IP Protections in Fast-Paced Cloud Environments Foley & Lardner LLP
Oct
19
2015
No Rehearing Of Biosimilar Patent Dance Decision Foley & Lardner LLP
Oct
2
2018
Blocking Patent Discounts Objective Indicia Of Non-Obviousness Foley & Lardner LLP
Dec
10
2018
Federal Circuit Protects Novartis Gilenya Patent From Obviousness-Type Double Patenting Foley & Lardner LLP
Aug
8
2023
How Rights Owners Can Be Proactive with CBP Enforcement Foley & Lardner LLP
May
7
2019
A Patent War Without Fighting? Foley & Lardner LLP
Oct
23
2023
Safeguarding AI Innovation in Stem Cell Therapy Foley & Lardner LLP
May
28
2019
Congress Releases Draft Patent Eligibility Legislation Foley & Lardner LLP
Jun
19
2019
The State of Patent Eligibility – Report on Senate Hearings Foley & Lardner LLP
Aug
27
2019
Federal Circuit Contrives Substantially Similar Written Description Test Foley & Lardner LLP
Jan
31
2024
Sotera Stipulation Filed After the Patent Owner’s Response Still Deemed Effective Foley & Lardner LLP
Feb
7
2024
Startup Advisors: When Should Startups Think About Branding? [Video] Foley & Lardner LLP
Sep
25
2019
After-Final Response Does Not Stop PTA Clock Foley & Lardner LLP
Feb
19
2024
USPTO Releases Guidance on Rule 132 Declarations Foley & Lardner LLP
Oct
15
2019
While Tempting, PTAB Requests for Rehearing Face Long Odds Foley & Lardner LLP
Jun
7
2016
PTAB Institutes Post Grant Review Against Chemical Process Patent Foley & Lardner LLP
Jul
14
2016
Janssen Seeks Injunction Against Remicade Biosimilar Based On Cell Culture Patent Foley & Lardner LLP
Aug
23
2016
Federal Circuit Affirms Tygacil Formulation Patent Foley & Lardner LLP
May
28
2020
Global Patent Portfolios of the Top 25 Well-Funded AV Companies Foley & Lardner LLP
Oct
5
2016
Sovereign Immunity of State Universities: Can It Shield Them from AIA Patent Challenges? Foley & Lardner LLP
Nov
8
2016
USPTO Examination Time Goals -- How Much Time Should Examiners Have To Examine Patent Application? Foley & Lardner LLP
Apr
11
2017
PTAB Not Bound By Prior Court Decisions Upholding Exelon Patents Foley & Lardner LLP
Apr
25
2017
No Nexus For Novartis Gilenya Patent Foley & Lardner LLP
May
16
2017
USPTO Patent Term Adjustment Error Costs Patent Owners Time And Money Foley & Lardner LLP
Apr
14
2015
Stricter Standing For Inter Partes Review? Foley & Lardner LLP
Apr
1
2022
Cases to Watch in 2022 Foley & Lardner LLP
Jun
23
2022
Fintiv Discretionary Denial of PTAB Proceedings Under New Director Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins